Prescient Therapeutics Ltd (PTX) — Capital Reinvestment Ratio

Latest as of June 1993: 0.32x

Prescient Therapeutics Ltd (PTX) has a Capital Reinvestment Ratio of 0.32x as of June 1993, meaning it reinvests 0% of its operating cash flow (AU$1.74 Million) in capital expenditures (AU$562.00K). Check Prescient Therapeutics Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.32x
Capex / Operating Cash Flow

Operating Cash Flow

AU$1.74 Million
AUD

Capital Expenditures

AU$562.00K
AUD

Data as of

Jun 1993
Most recent filing

Prescient Therapeutics Ltd Capital Reinvestment Ratio (1991–1993)

This chart tracks Prescient Therapeutics Ltd's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see PTX cash flow metrics.

Annual Capital Reinvestment Ratio for Prescient Therapeutics Ltd (1991–1993)

Year-by-year Capital Reinvestment Ratio for Prescient Therapeutics Ltd from 1991 to 1993. See Prescient Therapeutics Ltd (PTX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
1993 0.32x AU$1.74 Million AU$562.00K ▼ -12.3%
1991 0.37x AU$730.00K AU$269.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow